The present invention relates to a naphthylamide compound of the structure as represented by formula (I), medicinal salts, prodrugs and hydrates or solvates thereof, and also relates to a method of preparing the compounds, pharmaceutical compositions comprising the compounds and the uses thereof as protein tyrosine kinase inhibitors, particularly as VEGFR-2 inhibitors, in preparing drugs for preventing and treating diseases related to abnormal angiogenesis.
本发明涉及由式(I)表示的结构的
萘甲酰胺化合物、其药用盐、原药和
水合物或溶液,还涉及制备该化合物的方法、包含该化合物的药物组合物及其作为
蛋白酪氨酸激酶抑制剂,特别是作为 V
EGFR-2
抑制剂在制备预防和治疗与异常血管生成有关的疾病的药物中的用途。